
BlackRock Capital Allocation Trust (BCAT) Stock Overview
Explore BlackRock Capital Allocation Trust’s financial performance, market position, analyst ratings, and future outlook.
BlackRock Capital Allocation Trust (BCAT)
Key Financials
Key Financials
Market Cap
1.7B
P/E Ratio
7.66
EPS (TTM)
$2.12
ROE
0.13%
BCAT Stock Analysis & Investment Overview (NYSE)
Our AI-powered analysis of BlackRock Capital Allocation Trust (NYSE: BCAT) gives investors deep insight into how the stock performs on the NYSE exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, BlackRock Capital Allocation Trust's NYSE-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of BCAT on the NYSE shows an RSI of 52.85, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $15.41 for the NYSE listing.
Key metrics behind BlackRock Capital Allocation Trust's NYSE-traded stock include a P/E ratio of 7.66 and a market capitalization of 1.7B. Combined with our AI analysis, these give both institutional and retail investors a clear view of BCAT on the NYSE.